Rat poison-contaminated synthetic cannabinoids caused severe bleeding in 16 patients, costing thousands per hospitalization | Research

The takeaway

In a 16-patient cohort with bleeding from synthetic cannabinoids contaminated with the rat poison brodifacoum, 75% had severely elevated clotting times at presentation, one patient died, and average treatment cost was $5,300 per hospitalization.

Emergency physicians, hematologists, and public health officials responding to contaminated drug outbreaks.

92% brodifacoum positive

What the researchers found

Hematuria was the most common bleeding symptom. 75% had INR >9.6 at presentation (normal is ~1.0). 92% of those tested were positive for brodifacoum. 75% achieved INR below 2 within 24 hours of treatment. One patient (6%) died. Median hospital stay was 4 days. Average pharmacological treatment cost was $5,300.

Why it matters

The brodifacoum contamination outbreak demonstrated that synthetic cannabinoid dangers extend beyond the drugs themselves to their unregulated manufacturing. This series provides a practical management algorithm for a toxicity pattern emergency physicians may encounter again.

The numbers in context

16 patients. INR >9.6: 75%. Brodifacoum positive: 12/13 tested (92%). INR <2 within 24 hours: 75%. Death: 1/16 (6%). Median hospital stay: 4 days (IQR 3-6). Average treatment cost: $5,300 (range $2,241-$8,086).

How the study worked

Observational case series of 16 patients with suspected exposure to LAAR-contaminated synthetic cannabinoids and associated bleeding, treated within the Johns Hopkins Health System. Management included IV/oral vitamin K, blood products, and laboratory monitoring.

What this study cannot tell us

Single health system cohort. Long-term outcomes after discharge not reported. Brodifacoum has a very long half-life, so patients may need prolonged vitamin K treatment beyond the study period. Specific SC compounds not identified.

How to read the evidence

Rated moderate because this is a systematic case series from an academic health system with consistent treatment protocols, though it is observational.

When this study was published

Published in 2019. Similar contamination outbreaks have been reported in multiple US states.

The bigger picture

Contaminated synthetic cannabinoids represent a public health failure of unregulated drug markets. The brodifacoum contamination pattern, seen across multiple US outbreaks, shows how prohibition can create dangers that would not exist with regulated products.

Questions still open

How long do patients need vitamin K after brodifacoum exposure? Are there other contaminants in synthetic cannabinoid products that have not been detected? Would rapid brodifacoum testing change emergency management?

Common questions

Why were synthetic cannabinoids contaminated with rat poison?

The reason for brodifacoum contamination is not entirely clear. It may be intentional adulteration or contamination during manufacturing. Brodifacoum is a potent anticoagulant that causes severe, prolonged bleeding.

How is this treated?

The management algorithm includes intravenous and oral vitamin K, careful use of blood products, and close lab monitoring. Most patients achieved improved clotting within 24 hours, but brodifacoum has a long half-life requiring extended treatment.

Read the original research

Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations.

Medicine, 98(36), e17015

View on PubMed ↗Publisher’s paper ↗

Citation

Bahouth, Mona N; Kraus, Peggy; Dane, Kathryn; Plazas Montana, Manuela; Tsao, William; Tabaac, Burton; Jasem, Jagar; Schmidlin, Holly; Einstein, Evan; Streiff, Michael B; Shanbhag, Satish. (2019). Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations.. Medicine, 98(36), e17015. https://doi.org/10.1097/MD.0000000000017015